Zydus Lifesciences Limited Press Release Feb 17 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release announcing that it received final approval from the USFDA for Sirolimus Tablets in two dosages. The tablets are used to prevent organ rejection in kidney transplant patients and to treat a rare lung disorder. The manufacturing will take place at the company's facility in Moraiya.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Feb 15 2023
- Press Release Jan 27 2023
- Press Release Jan 16 2023
- Press Release Jan 12 2023
- Press Release Jan 10 2023
Later from Zydus Lifesciences
- Zydus Lifesciences Limited Press Release Feb 20 2023
- Press Release Feb 24 2023
- Press Release Feb 28 2023
- Press Release Mar 02 2023
- Press Release Mar 03 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences